Becton Dickinson falls after lowering 2026 profit forecast

Shares of medical device maker Becton Dickinson BDX.N fall 2.6% to $204.84

Co lowers forecast for 2026 adj. profit per share to between $12.35 and $12.65, compared with prior forecast of $14.75 to $15.05

*J.P.Morgan says "We're not surprised to see management holding guidance steady given its conservative guidance ethos and likely volatility associated with the upcoming separation, but reiterated guidance is unlikely to get investors off the sidelines this early in the turnaround"

Analysts were expecting annual adj. profit per share of $14.72, according to data compiled by LSEG

*"Full-year adjusted EPS of $12.35-12.65 brackets what we think were investor expectations for $12.50, which assumes $4 billion cash distribution from Waters WAT.N, with $2 billion deployed to share repurchases and $2 billion to debt paydown" - J.P.Morgan

BDX reports Q1 adj. profit per share of $2.91 vs estimates of $2.81

Posts quarterly revenue of $5.25 billion, beating estimates of $5.15 billion

Up to last close, BDX down 8.51% in the last 12 months